Delivery Order SPE2DB22D3301-SPE2DB25FX8QT

Award Date 1/16/25
Potential Completion Date 1/17/25
Potential Value $7.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $62,360.08, is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,290.24 firm fixed price delivery order covers the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of January 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,941.94 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The award has an ultimate completion date of November 8, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,701.24, is a delivery order for the supply of RENFLEXIS 100 MG VIALS. The contract has an ultimate completion date of January 30, 2025 and is a firm fixed-price contract. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,727.50 firm fixed price delivery order is for the supply of RENFLEXIS 100 MG VIALS medical products. The contract has an ultimate completion date of February 3, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $7,607.10 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of RENFLEXIS 100 MG VIALS, a pharmaceutical product, with a period of performance through October 10, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999, for...
This federal contract award, with a ceiling value of $7,009.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,963.32 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG vials, a specialty medication. The contract has a completion date of July 5, 2022 and was awarded on July 1, 2022. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,339.47 firm fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS medical products. The contract has an ultimate completion date of November 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,725.04 firm-fixed-price delivery order is for the supply of RENFLEXIS 100 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FX8QT
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,087.70, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, worth up to $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. This specific Delivery Order is for the product "RENFLEXIS 100 MG VIALS" and has a firm fixed price. The contract has an ultimate completion date of January 17, 2025 and was awarded on January 16, 2025. The contract does not have a set-aside designation, indicating open competition.

Generated 4/18/25, 1:55 AM